What is the difference between EU MDR and MDD?

EU MDR (Regulation (EU) 2017/745) replaced the Medical Device Directive (MDD 93/42/EEC) and significantly raised the bar for clinical evidence, Post-Market Surveillance, Notified Body involvement, and technical documentation requirements. Devices previously certified under MDD required EU MDR transition by May 2024, with extended timelines applying for some legacy devices. New devices must comply with EU MDR from the start.

What is EUDAMED and is registration required?

EUDAMED (European Database on Medical Devices) is the EU's centralized database for medical device registration, UDI assignment, economic operator registration, and vigilance reporting. Registration in EUDAMED is mandatory for all devices placed on the EU market under EU MDR. EEA Innovations supports EUDAMED registration as part of a CE Marking program.

What is IVDR and is it different from EU MDR?

IVDR (Regulation (EU) 2017/746) is a separate regulation covering in vitro diagnostic medical devices, which are devices used for examining specimens from the human body, such as blood tests, PCR assays, and glucose monitors. While IVDR shares many structural similarities with EU MDR, it has its own classification rules, performance requirements, and transition timelines. EEA Innovations supports IVDR compliance for IVD developers.

Global Medical Device Regulatory Consulting & Market Access

Q: Can EEA Innovations run FDA and EU MDR programs in parallel?

Yes. This is often the most efficient approach. EEA Innovations structures testing programs, quality systems, and documentation to satisfy both FDA and EU MDR requirements within a single coordinated framework wherever possible, avoiding the cost and time of rebuilding documentation market by market.

Europe Medical Device Regulatory Consulting

Home
/
Europe Medical Device Regulatory Consulting

EU MDR. CE Marking. Full Compliance.

Europe Medical Device Regulatory Consulting for EU MDR & CE Marking

The European medical device market is governed by the EU Medical Device Regulation (EU MDR), which sets strict requirements for clinical evidence, Technical Documentation, Post-Market Surveillance, and regulatory compliance. EEA Innovations provides end-to-end Europe medical device regulatory consulting to help MedTech companies achieve CE Marking, maintain EU MDR compliance, and successfully enter the European market. With 20+ years of experience and 10+ cleared products, we support everything from device classification and regulatory strategy to Technical Documentation, quality systems, submissions, and post-market compliance, guiding companies from concept to commercialization.

What We Do

EU MDR & CE Marking Consulting Services

Whether you are entering one market or three simultaneously, EEA Innovations structures a regulatory program that integrates across regions — minimizing duplicated testing, aligning documentation strategies, and building a quality system that satisfies multiple regulatory bodies.

What Is EU MDR and Who Does It Apply To?

EU MDR (Regulation (EU) 2017/745) is the European Union’s primary regulatory framework for medical devices placed on the EU market. It applies to manufacturers based inside or outside the EU who wish to sell medical devices in any EU member state — including the United Kingdom under UKCA (post-Brexit), Switzerland, and other EEA countries.

EU MDR applies to:

US and global companies entering the European market
Existing MDD-cleared devices requiring MDR transition
New devices developed for EU market launch
GCC companies seeking FDA or CE Marking clearance
In vitro diagnostic devices under IVDR 2017/746
Software as a Medical Device (SaMD) targeting EU users
Combination products incorporating a medical device component

CE Marking under EU MDR is the mandatory conformity mark that demonstrates a device meets European safety, performance, and clinical requirements. Without it, no medical device can be legally placed on the EU market.

Who EEA Innovations Supports for EU MDR Compliance

US MedTech companies entering the European market for the first time
Startups developing Class IIa or IIb devices for EU launc
Companies transitioning MDD-cleared devices to EU MDR
Manufacturers of implantable, active, or higher-risk Class III devices
Software and AI medical device developers targeting EU users
IVD manufacturers preparing for IVDR compliance
Global companies seeking a coordinated FDA + EU MDR regulatory program
University research and innovation teams moving toward CE Marking

Frequently Asked Questions

EU MDR, Regulation (EU) 2017/745, replaced the previous Medical Device Directive framework and significantly raised expectations for clinical evidence, Post-Market Surveillance, Notified Body involvement, Technical Documentation, and lifecycle compliance. Certain legacy devices may still be subject to specific transition provisions, but new devices must be planned under EU MDR from the beginning.

Yes. Manufacturers based outside the EU must designate an Authorized Representative (AR) established within the EU. The AR is the legal point of contact with competent authorities and is registered in EUDAMED. EEA Innovations can advise on AR selection and obligations as part of an EU market entry program.

Timelines vary significantly by device class and clinical evidence availability. Class I self-declaration can take 3–6 months for documentation preparation. Class IIa and IIb devices involving a Notified Body typically require 12–24 months from strategy to CE Marking, depending on Notified Body capacity and clinical evidence maturity. Class III devices generally require 18–36 months or longer.

As early as feasibility. Regulatory planning that begins during concept development allows design controls, testing protocols, and documentation to be structured for global requirements from the start — rather than rebuilt market by market later in the process.

Yes — and this is often the most efficient approach. EEA Innovations structures testing programs, quality systems, and documentation to satisfy both FDA and EU MDR requirements within a single coordinated framework wherever possible, avoiding the cost and time of rebuilding documentation market by market.

A Notified Body is a conformity assessment organization designated by an EU member state to evaluate medical devices against EU MDR requirements. Notified Body involvement is required for Class IIa, IIb, and III devices — covering QMS audits, Technical File review, and clinical evaluation assessment. Class I devices (non-sterile, non-measuring, non-reusable surgical) can be self-declared by the manufacturer.

IVDR (Regulation (EU) 2017/746) is a separate regulation covering in vitro diagnostic medical devices — devices used for examining specimens from the human body (blood tests, PCR assays, glucose monitors, etc.). While IVDR shares many structural similarities with EU MDR, it has its own classification rules, performance requirements, and transition timelines. EEA Innovations supports IVDR compliance for IVD developers.